The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335c1 · Cited by 1,425
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Wisse, B. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141966.69934.21 · Cited by 933
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · cited 1×
“In fact, like TNFa, IL-6 may interfere with insulin signaling [22], thereby favoring steatosis and inflammation, although somewhat discrepant results have been reported [23,24].”
ResultMonocyte chemoattractant protein-1 in human atheromatous plaques.
Nelken, N. A., Coughlin, S. R., Gordon, D., & Wilcox, J. N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115411 · Cited by 880
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Androgens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein
Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2734 · Cited by 837 · cited 1×
“Sex differences in plasma levels of adiponection are normally present [39], but if our findings reflect that the protective role of adiponectin in NAFLD is gender specific or whether it is due to low sample size will have to be further elucidated.”
BackgroundCrespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E
Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., & McClain, C. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50316 · Cited by 504
Ford, E. S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00134-5 · Cited by 314
Aukrust, P., Liabakk, N.-B., ller, F., Lien, E., Espevik, T., & Froland, S. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.420 · Cited by 292
Self-citationReinecker, H., Loh, E. Y., Ringler, D. J., Mehta, A., Rombeau, J. L., & MacDermott, R. P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90006-3 · Cited by 290
Marra, F., DeFranco, R., Grappone, C., Milani, S., Pastacaldi, S., Pinzani, M., Romanelli, R. G., Laffi, G., & Geñtilini, P. (1998) · Europe PMC (PubMed Central) · Cited by 289
Dahlman, I., Kaaman, M., Olsson, T., Tan, G. D., Bickerton, A. S. T., Wåhlén, K., Andersson, J., Nordström, E. A., Blomqvist, L., Sjögren, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0369 · Cited by 207
Hong, F., Radaeva, S., Pan, H.-N., Tian, Z., Veech, R., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.1840400424 · Cited by 202
Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α
Robinson, S. C., Scott, K. A., & Balkwill, F. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2<404::aid-immu404>3.0.co;2-x · Cited by 201
The isoprostanes in biology and medicine
Praticò, D. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00411-8 · Cited by 188
Grant, A. J., Goddard, S., Ahmed-Choudhury, J., Reynolds, G., Jackson, D. G., Briskin, M., Wu, L., Hübscher, S. G., & Adams, D. H. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62570-9 · Cited by 162
Bonacchi, A., Petrai, I., DeFranco, R., Lazzeri, E., Annunziato, F., Efsen, E., Cosmi, L., Romagnani, P., Milani, S., Failli, P., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01194-6 · Cited by 160
Aukrust, P., Berge, R. K., Ueland, T., Aaser, E., Damås, J. K., Wikeby, L., Brunsvig, A., Müller, F., Forfang, K., Frøland, S. S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01110-4 · Cited by 141
Self-citationHayashida, K., Nanki, T., Girschick, H. J., Yavuz, S., Ochi, T., & Lipsky, P. E. (2001) · Arthritis Research & Therapy · doi:10.1186/ar149 · Cited by 132
Diehl, A. M. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.012 · Cited by 126
Fisher, N. C., Neil, D., Williams, A., & Adams, D. (1999) · Gut · doi:10.1136/gut.45.3.416 · Cited by 103
Wu, T., Tsao, K., Chang, C. P. ‐., Li, C.-N., Sun, C., & Wu, J. T. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00172-9 · Cited by 99
Haukeland, J. W., Konopski, Z., Linnestad, P., Azimy, S., Løberg, E. M., Haaland, T., Birkeland, K. I., & Bjøro, K. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500264953 · Cited by 89
Self-citationLiver injury in the setting of steatosis: Crosstalk between adipokine and cytokine†
Czaja, M. J. (2004) · Hepatology · doi:10.1002/hep.20328 · Cited by 70
Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis
Liu, Z. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg172 · Cited by 37
Cited by
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0198-4 · Cited by 1,089
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Pathogenesis of non-alcoholic fatty liver disease
Dowman, J. K., Tomlinson, J. W., & Newsome, P. N. (2010) · QJM · doi:10.1093/qjmed/hcp158 · Cited by 741
Metadata
- Authors
- Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 44
- Issue
- 6
- Pages
- 1167-1174
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2016617561
- Cited by
- 603
- References
- 41
- FWCI
- 19.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.